India’s potential to beat tuberculosis
One-quarter of the world’s tuberculosis cases are in India, and the disease kills one Indian every 90 seconds. But India—strong in TB research and in technological and pharmaceutical capacity—has the potential to make great progress against TB, say…
Summit brings together U.S., China health leaders
October 6, 2015 — Public health practitioners, policy makers, and industry representatives from China and the U.S. gathered September 28–29, 2015, to share experiences and ideas around health system reform. The 5th U.S.–China Summit, hosted by Harvard T.H.…
Dealing with parents’ mistrust of vaccines
As the Disneyland measles outbreak continues to make headlines and fuel public debate, health professionals seek more effective ways to convince parents who mistrust vaccines to get their children vaccinated, according to Barry R. Bloom, Harvard University Distinguished…
A cross-disciplinary approach to eradicating malaria
December 17, 2014 –There is an arsenal of cost-effective tools available to combat malaria but getting people to adhere to treatment regimens can be challenging, said Jessica Cohen, assistant professor of global health, at a symposium focused on…
To stop Ebola, strengthen health systems in West Africa
The current Ebola crisis spread quickly in West African countries, some of the poorest in the world, where health systems are poorly developed or dysfunctional. The best way to contain the epidemic is for the international community to…
Talking the talk on vaccines
June 23, 2014 — Recent disease outbreaks have been traced to deliberately unvaccinated Americans—and anti-vaccine sentiment is a serious health concern. Barry Bloom, an infectious diseases expert at Harvard School of Public Health, thinks health care providers need…
Tuberculosis experts address role of immune response
Tuberculosis (TB) remains a major infectious disease global threat, with 8.7 million new cases and 1.4 million deaths worldwide reported in 2011 alone. In the United States, an estimated 10 million to 15 million people are infected. With…
As work on lethal bird flu research resumes, debate continues
Last week, an international group of scientists announced their intention to resume research on the potentially deadly H5N1 bird flu virus after a year’s hiatus, even as debate over the safety of the research continued. Researchers from the…
Making the case to continue an innovative anti-malaria program
November 7, 2012 -- Funding at Risk for Program That Increases Availability, Lowers Costs for Most Effective Drugs A two-year-old pilot program that aims to protect the most effective drug for malaria from resistance, through a novel economic strategy…
Debate heats up about contentious bird flu research
Article on NPR mentioning HSPH’s Marc Lipsitch and Barry Bloom, October 9, 2012